Recall Of Hip Replacement Device Component Given Class I Designation By FDA
This article was originally published in The Gray Sheet
Executive Summary
A hip replacement component made by MicroPort Orthopedics is being recalled due to a risk of sudden fracture. Possible complications include neurovascular damage, hemorrhage and death.
You may also be interested in...
Wright, MicroPort Deal Signals Shifts In Global Ortho Industry
Wright, by selling its hip-and-knee reconstruction business, is abandoning the stagnant U.S. large-joint sector, choosing instead to tie its future to the faster growing extremities market. Shanghai-based MicroPort, meanwhile, is looking to compete in China’s growing large-joint market.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.